HOXD13 and neoplasm: The sPD1-p24fc/EP/AB1-GAG (group I) proved to be significantly more efficient than controls at rejecting implanted WT-AB1 cells (Figure 3B, **P = 0.0098), and most protected mice (9/10, 90%) remained tumor-free.